• DNDi - Best Science for the Most Neglected 20 Years
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic Preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • HELP Helminth Elimination Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi Southern Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
DNDi - Best Science for the Most Neglected 20 Years
  • DNDi - Best Science for the Most Neglected 20 Years
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic Preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • HELP Helminth Elimination Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi Southern Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > News

DNDi participating at 2nd Global Health Forum of the Boao Forum for Asia to discuss key issues in hepatitis C treatment

Home > News

DNDi participating at 2nd Global Health Forum of the Boao Forum for Asia to discuss key issues in hepatitis C treatment

Boao Forum for Asia 2021
1 Jun 2021
Share on twitter
Share on facebook
Share on linkedin
Share on email
Share on print
  • English
    • English
    • 中文

Sub-forum on hepatitis C strategies in LMICs – Towards elimination of hepatitis C in Asia: Moving from unaffordable treatments to accessible solutions will be chaired and moderated by Dr Chen Zhongdan, Technical Officer, Hepatitis/TB/HIV/STI, at WHO China.

The 2nd Global Health Forum (GHF) of the Boao Forum for Asia, with the slogan ‘Health for All’, will bring together representatives from governments, not-for-profit organizations, academia, and the private sector to explore the conference theme of ‘Health Beyond Health: In the Year of Sustainable Development 2030‘ through a series of online and offline sessions and activities, with the aim of fostering global cooperation in public health.

The Global Health Forum will focus on three distinct areas: Universal Health Coverage, Innovation for Health, and Health for All Policies. The Forum’s 4-day agenda will include an opening ceremony, two general meetings, 33 sub-forums, and 15 events bringing together over 1,500 in-person participants and a virtual audience of 100 million.

Drugs for Neglected Diseases initiative (DNDi) has been invited to speak at the session ‘Towards elimination of hepatitis C in Asia: Moving from unaffordable treatments to accessible solutions‘ on 3 June 2021 (1:30pm-3:00pm CST / 7:30am-9:00am CEST). This session will focus on the initiatives led by low- and middle-income countries (LMICs) in Asia to meet the WHO 2030 elimination targets for hepatitis C.

This year is the first occasion that Dr Marie-Paule Kieny, Chair of the Board of DNDi has been invited to give a keynote address at the Global Health Forum sub-forum on hepatitis C. Dr Kieny will cover the DNDi collaborative R&D model with an emphasis on equitable and sustainable access to treatment for the most neglected populations.  She will also discuss the need for new players with strong leadership from the Global South to innovate and bridge essential health gaps for the most neglected.

DNDi Chair, Dr Marie-Paule will be joined by five panelists at the sub-forum: Malaysia’s Director-General of Health, Dr Noor Hisham bin Abdullah; Ms Zhu Zhenyan, Third World Network (TWN); Mr Mickael Le Paih, Head of Mission MSF, Cambodia; Dr Jing Sun, Associate Professor of Pharmaceutical Policy, Peking Union Medical College (PUMC); and Dr Jinzi J. Wu, Founder, Chairman and CEO, Ascletis, China.

The LMIC led panel will discuss key issues in hepatitis C treatment and present tried and tested tools and strategies that may help to shape China’s hepatitis C elimination journey. The key areas of this discussion include:

  • Addressing IP barriers in hepatitis C treatment for improved access strategies for LMICs
  • Hepatitis C public health leadership: Malaysia’s hepatitis C journey – access, affordability, testing, and decentralization strategies
  • Financing and delivering the hepatitis C treatment in China – Overcoming barriers for patient access
  • Hepatitis C public health scaling-up: Diagnostics and treatment strategies to enable scale-up and a public health approach to hepatitis C – Case study from treatment programme in Preah Kossamak Hospital, Phnom Penh, Cambodia
  • Hepatitis C innovation, production, public health scaling-up

For more information, please visit: http://www.ghfbfa.cn

Photo credit: Xinhua/Yang Guanyu

Hepatitis C Asia China

Read, watch, share

Loading...
Doctor with patient in hospital setting
Press releases
5 Dec 2023

Cryptococcal meningitis: new report highlights slow uptake of guidelines shown to reduce deaths in Africa

Healthcare worker with patient
Press releases
3 Dec 2023

Germany’s Federal Ministry for Economic Cooperation and Development (BMZ) through KfW grants funding to fast-track access to medicines for poverty-related and neglected diseases

Laboratory staff working
News
3 Dec 2023

DNDi commits to cutting carbon emissions in half by 2030

People entering the Mycetoma Research Centre
Videos
23 Nov 2023

Mycetoma: Neglected but not Forgotten

Nurse caring for patient with a lesion on the feet
Press releases
23 Nov 2023

World’s first clinical trial for devastating fungal disease mycetoma shows efficacy of new, promising treatment

People standing under tents at the Run for Neglected Patients
News
23 Nov 2023

DNDi@20 charity run shines the spotlight on neglected diseases in Kenya

Viewpoints
20 Nov 2023

Africa Statistics Day: Statistics save lives, especially those of neglected patients

Africa Uncensored
Viewpoints
13 Nov 2023

Doenças negligenciadas ameaçam saúde pública global

Folha de S. Paulo
VIEW ALL

Help neglected patients

To date, we have delivered twelve new treatments, saving millions of lives.

Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there. 

GIVE NOW
DNDi - Best Science for the Most Neglected 20 Years
Facebook-f
Twitter
Instagram
Linkedin-in
Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License